BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 30111807)

  • 21. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
    Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
    Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
    Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
    Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
    Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
    Qiu G; Ma D; Li F; Sun D; Zeng Z
    Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma.
    Jiao M; Ning S; Chen J; Chen L; Jiao M; Cui Z; Guo L; Mu W; Yang H
    Int J Oncol; 2020 Jun; 56(6):1455-1467. PubMed ID: 32236578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
    Jiang T; Wang C; Zhu Y; Han H
    J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells.
    Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL
    Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
    Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
    Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA HOTAIR promotes carcinogenesis and invasion of gastric adenocarcinoma.
    Lee NK; Lee JH; Park CH; Yu D; Lee YC; Cheong JH; Noh SH; Lee SK
    Biochem Biophys Res Commun; 2014 Aug; 451(2):171-8. PubMed ID: 25063030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.
    Zhang D; Li H; Xie J; Jiang D; Cao L; Yang X; Xue P; Jiang X
    Int J Oncol; 2018 Jun; 52(6):1777-1786. PubMed ID: 29620172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.